FIELD: biotechnology.
SUBSTANCE: invention is the use of the human cell carcinoma of the kidney cancer RC291C, expressing cancer-testicular antigens stored in the specialized collection of vertebrate cell cultures of the Russian cell culture collection under the registration number RKKK (P) 724D for the preparation of biomedical cell products and testing of antitumor bio-and chemotherapy drugs.
EFFECT: invention allows to increase the effectiveness of treatment and increase the life expectancy in the treatment of malignant tumors.
1 cl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| HUMAN BLADDER CANCER CELL LINE 198 BLCAN RLA | 2019 |
|
RU2733230C1 |
| APPLICATION OF HUMAN SKIN MELANOMA CELL LINE 388mel | 2018 |
|
RU2675541C1 |
| HUMAN BLADDER CANCER CELL LINE 190 BICAN KAG | 2021 |
|
RU2779948C1 |
| HUMAN BLADDER CANCER CELL LINE 398 BLCAN KAE | 2020 |
|
RU2742245C1 |
| HUMAN OVARIAN CANCER CELL LINE 533 OOS | 2017 |
|
RU2650759C1 |
| HUMAN COLORECTAL CANCER CELL LINE 485 COLO CAN | 2017 |
|
RU2650757C1 |
| APPLICATION OF CELL LINE OF 369 ADMEL HUMAN SKIN MELANOMA | 2017 |
|
RU2642265C1 |
| HUMAN BLADDER CANCER CELL LINE 587 BLCAN TVV | 2020 |
|
RU2742244C1 |
| CELL LINE OF HUMAN KIDNEY CANCER IBGVAT R 27 | 2014 |
|
RU2573938C1 |
| METHOD FOR STIMULATING PRESENTING ACTIVITY OF DENDRITIC CELLS | 2019 |
|
RU2728592C1 |
